The path from lead to candidate selection can include many crossroads, where choosing the right science at the right time can determine a program’s ultimate success. Charles River provides drug discovery support in a contract research capacity, with a strategic partner approach. From candidate screening to safety assessment, early drug discovery determinations are supported by our collective expertise across the complete drug development spectrum.
Our staff is well-versed in simple to complex phenotyping and interpretation across all major therapeutic areas. We offer a range of challenge models mimicking human disease, as well as pathophysiological analysis and insights on the transition to the human condition(s). Studies are conducted in a highly controlled environment to minimize variability when phenotyping across lines and to ensure high-quality data that is both robust and reproducible.